Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

September 15, 2023 Editor 0

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain EraserTop Industry Innovation Award for 2023 Recognizes the Dental Pain Eraser’s Pioneering Pain-Free Orthodontic Approach

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser
Award Winning Dental Pain Eraser

The Synapse Dental Pain Eraser won the prestigious 2023 Orthodontic Innovator Award at the American Association of Orthodontists annual meeting.

Sakowitz Smiles Orthodontics is taking a revolutionary step in the world of orthodontic care by incorporating cutting-edge technology known as the Dental Pain Eraser. This innovation is poised to transform the orthodontic treatment experience, making it more comfortable and virtually pain-free for patients.

In the realm of healthcare, orthodontists and dentofacial orthopedists often serve as the first professionals to introduce younger patients to real, lasting physical discomfort. However, Sakowitz Smiles Orthodontics believes that this should not be the defining image of orthodontic care for children and adults alike.

“We are committed to creating positive memories for our patients,” says Dr. Scott Sakowitz, founder and lead orthodontist at Sakowitz Smiles Orthodontics. “We understand that orthodontic treatment can be challenging, especially for children. Our goal is to ensure that the pain associated with orthodontic procedures becomes a thing of the past.”

“The Dental Pain Eraser is a groundbreaking technology that allows us to provide immediate relief from soft tissue pain and general orthodontic discomfort. Applying this remarkable device for just 10-15 seconds along the root surface can dramatically reduce the discomfort experienced during orthodontic visits. From wire activations to separator placements to aligner adjustments, every step of the journey now feels significantly more comfortable.”

“The relief is real, and it’s transformative,” adds Dr. Sakowitz. “The Dental Pain Eraser isn’t just remarkably effective; it’s possibly the fastest, easiest, and only drug-free method for reducing soft tissue pain in the orthodontic arena.”

In a recent study published in the Journal of Clinical Orthodontics, 84% of the subjects who used the Dental Pain Eraser experienced pain relief in less than 2 minutes. An astonishing 44 out of 45 subjects reported experiencing orthodontic pain relief, often lasting for at least 48 hours.

The American Association of Orthodontists recognized the significant impact of the Dental Pain Eraser by awarding it the top industry innovation award for 2023. This prestigious accolade underscores the device’s effectiveness in making orthodontic treatment more comfortable and pain-free.

The introduction of the Dental Pain Eraser at Sakowitz Smiles Orthodontics signifies their commitment to delivering the highest level of care to their patients. It is a significant step toward making orthodontic treatment a more comfortable and pain-free experience.

For more information about Sakowitz Smiles Orthodontics and the Dental Pain Eraser, please visit https://orlandoorthodontics.com or contact them at (407) 627-1187.

About Sakowitz Smiles Orthodontics

Sakowitz Smiles Orthodontics is a leading private orthodontic practice dedicated to providing exceptional orthodontic care for patients of all ages. Dr. Sakowitz and the team at Sakowitz Smiles Orthodontics are committed to creating beautiful smiles while ensuring a comfortable and pain-free journey for every patient.

Contact Information:

Leidy Collado

Practice Manager

[email protected]

4076271187

Scott Sakowitz

Owner, Orthodontist

[email protected]

4076271187

Related Images


Award Winning Dental Pain Eraser

Award Winning Dental Pain Eraser

The Synapse Dental Pain Eraser won the prestigious 2023 Orthodontic Innovator Award at the American Association of Orthodontists annual meeting.

Original Source:

Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser

The post Pioneering Pain-Free Orthodontic Care: Sakowitz Smiles Orthodontics Introduces Dental Pain Eraser appeared first on AESTHETIC NEWS.

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

September 15, 2023 Editor 0

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide UseThe Impact of Semaglutide on Cosmetic Procedures: An Insight into Emerging Trends

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use
Stock Photo ID: 561920116. Shutterstock. Africa Studio. 2023

Mature woman’s body before and after weight loss on white background. Health care and diet concept.

Over the last few years, the landscape of plastic surgery has seen remarkable changes. Dr. Robert Kratschmer, a board-certified plastic surgeon based in Houston, sheds light on how the popularization of the drug Semaglutide is affecting patient choices in cosmetic procedures.

“Two years ago, liposuction and fat transfer were the procedures that dominated patient interest,” says Dr. Kratschmer. “While they remain popular, the rise of Semaglutide for weight management has led to a notable increase in other procedures, like panniculectomy, thigh lift, arm lift, and neck lift surgeries.”

Semaglutide, originally developed for the treatment of type 2 diabetes, has been growing in prominence for its off-label use in weight management. This has had ripple effects in the plastic surgery community.

Dr. Kratschmer explains, “Semaglutide has offered a non-surgical option for weight loss, which is changing the kinds of procedures people are seeking. Many of my patients have successfully used it for weight loss, but are then left with excess skin that they want to address. As a result, we’re seeing a considerable uptick in surgeries designed to remove excess skin and contour the body.”

This shift is significant, not only for prospective patients but also for the medical community at large. The rising interest in these procedures suggests that people are becoming increasingly conscious of comprehensive body transformations that focus on both weight loss and body contouring.

“Every medical advancement impacts patient choices,” Dr. Kratschmer says. “As physicians, we must adapt and continue to offer the best care based on emerging trends and technologies. It’s an exciting time in the field of plastic surgery, and I’m eager to see how this evolves in the years to come.”

For those considering plastic surgery, Dr. Kratschmer advises consultations to discuss individual needs and options. “Patient care is always our utmost priority. Our consultations aim to guide patients through the variety of choices now available, so they can make informed decisions that align with their goals,” he concludes.

To learn more about Dr. Robert Kratschmer and his practice, please visit SiliconeMD.com.

About Dr. Robert Kratschmer

Dr. Robert Kratschmer is a board-certified plastic surgeon with over 20 years of experience. Based in the Greater Houston area, he specializes in a wide range of cosmetic procedures and is committed to providing exceptional care for his patients.

Contact Information:

Amber K.

Practice Manager

[email protected]

2813178179

Original Source:

Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use

The post Board-Certified Plastic Surgeon Dr. Robert Kratschmer Discusses Shifts in Plastic Surgery Trends Amidst Rising Semaglutide Use appeared first on AESTHETIC NEWS.

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

September 14, 2023 Sam M 0

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

Unveiling the Potential Breakthrough – Activating Stem Cells to Delay and Reduce Dementia and Depression Risk

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group
Dr. Lee & Dr. Lin

Dr. Jia-Fu Lee from Tzu Chi Hospital & Dr. Chai-Ching Lin from Power-Stem Biomedical

Alzheimer’s disease and dementia severity in the United States is escalating, posing a growing public health crisis. With an aging population, millions are affected by these devastating conditions. The ratio of Alzheimer’s patients in the 65+ demographic has reached 1 in 9 based on the study by the American CDC (Center of Disease Control and Prevention), highlighting the urgent need for research, care improvements, and increased awareness to address their profound social, economic, and emotional impact.

In response to World Alzheimer’s Month, Taipei Tzu Chi Hospital and Power-Stem Biomedical Group (Parent Company of Beauty-Stem Biomedical) jointly held a symposium. Dr. Jia-Fu Lee from Tzu Chi Hospital and Dr. Chai-Ching Lin, the President of Power-Stem Biomedical, discussed the testing data from a human trial program. 

“Our momentous achievement has arrived!” declared Dr. Chai-Ching Lin, President, Power-Stem Biomedical. “We proudly introduce the world’s first stem cell supplement, underwent by rigorous clinical trials and scientific validation. This marks an exciting breakthrough in regenerative supplements, a new chapter in our commitment to advancing science and improving lives.”

They assessed brain degeneration by measuring Alzheimer’s Disease Risk Index (ADRI) and CD34+ hematopoietic stem cell levels through scientific and quantitative blood tests after the usage of CD34 NU-Signals. It has been observed that when individuals start to notice memory and cognitive decline, the number of stem cells in their bodies also decreases significantly. Clinically, early detection and prevention are possible through a healthy diet, quality sleep, and regular exercise. And refer to the study, activating autologous stem cells through stem cell nutrients can significantly reduce value of ADRI risk index and increase stem cell count.

Dr. Lee from Taipei Tzu Chi Hospital’s Dementia Care Center stated that by analyzing brain waves with ADRI technology, and evaluating the risk of dementia through blood tests, it is possible to objectively detect the levels of depression and dementia risk. Through personalized regenerative supplement, mental well-being, exercise, and quality sleep, one can regain cardiovascular and brain health vitality.

Dr. Lin has been researching the field of stem cells for many years, and she has contributed significantly to stem cell nutrition. She has published multiple patents, scientific journals, and books. Dr. Lin emphasizes the importance of paying attention to one’s “Health Deposit” after the age of 40. Therefore, tracking CD34+ hematopoietic stem cells, NK natural killer cells, and ADRI annually are crucial life indicators to better understand one’s hematopoietic capacity, immune system, and self-healing ability.

Dr. Lee added that, especially in the case of ADRI values, they should be improved to reach a score of 0. Maintaining a happy and contented mind is essential for effectively staying away from depression and dementia.

Contact Information:

Kaihsiang Lee

Marketing Manger

[email protected]

888-341-7505

Related Files
Beauty-Stem US Health Deposit.pdf
CD34 Nu-Signals DM.pdf

Original Source:

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

The post CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group first appeared on Enrose Magazine.

The post CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group appeared first on IGP Beauty.